Modern methods of treatment of cervix inflammatory diseases in women of reproductive age. Literature review

А. Е. Дубчак, А. В. Милевский

Abstract


The article describes contemporary views on the problem of inflammatory diseases of the cervix uterus – cervicitis with the presence of ectopia, erosion, ectropion or without them. The emphasis is placed on the fact that the development of the disease occurs due to two reasons: the persistent action (persistence) of the pathogen – the etiology of inflammation; increased concentration of proinflammatory cytokines – tumor necrosis factor and interleukin-1 – pathogenesis of inflammation. Cytokine-induced activation and output of leukocytes from the vascular bed leads to tissue damage, the development of clinical manifestations of inflammation, promotes chronization of the process and the occurrence of relapses. Therefore, rational treatment of inflammatory diseases of the cervix must be comprehensive and include an etiotropic and pathogenetic component.

When choosing etiotropic therapy, it is necessary to take into account the increasing resistance of pathogens to major activated heric remedies. In this case, resistance to nitrofuran occurs very rarely. Nifuratel (Macmiror Complex) is a nitrofuran of the last generation, the only preparation of this group for local application in gynecology, has a pronounced bactericidal effect against a wide range of pathogens (bacteria, mushrooms, protozoa) and provides a reliable eradication of microorganisms. In the Macmiror Complex vaginal cream, the expressed bactericidal effect of nifuratel is combined with high fluidity and pronounced adhesive properties of the carbomeric basis of the cream, which provides a reliable coating of the cervix and a high concentration of the active substance in the focal point of the lesion.

Benzodiamine hydrochloride (Tantum RosaR) is the only local non-steroidal anti-inflammatory agent in gynecology, which provides powerful suppression of the synthesis of proinflammatory cytokines, the tumor necrosis factor and interleukin-1, at the very earliest stages, as the recommended pathogenetic therapy of inflammation. Thus, the combination therapy of Macmiror Complex vaginal cream (nifuratel) and Tantum RosaR (benzidamine hydrochloride) has a comprehensive effect on the etiology and pathogenesis of the disease, provides a compelling clinical recovery and prevent relapse in inflammatory diseases of the cervix.


Keywords


cervicitis; ectopia and erosion of the cervix; etiology and pathogenesis of inflammation; benzidamine hydrochloride; Tantum Rosa; Nifuratel; Macmiror Complex

References


Sukhikh, T.G. Reproductive health of family. Materials of the second International congress on reproductive medicine “Reproductive health of family”. Moscow (2008): 5–10.

Ovsyannikova, Т.V. Diseases of the cervix. Clinic, diagnosis, treatment: a manual for doctors. Мoscow. MEDpress-inform (2013): 64 p.

Panchenko, V.V. Clinical and morphological characteristics, optimization of diagnosis and treatment of complicated ectopy of the cylindrical epithelium of the cervix. Thesis abstract for PhD degree, specialty 14.01.01, 14.03.02. Chelyabinsk (2014): 16 p.

Бебнева, Т.Н. Роль инфекционных факторов в развитии доброкачественных и предраковых заболеваний шейки матки. – АНО «Открытые Медицинские Коммуникации», 2017–2018.

Bebneva, T.N. The role of infectious factors in the development of benign and precancerous diseases of the cervix. ANO “Open Medical Communications” (2017–2018).

Grenkova, Y.M. Inflammatory diseases of the cervix in women of reproductive and postmenopausal age: the features of the clinic, diagnosis and treatment. Thesis abstract for PhD degree, specialty 14.01.01. Sankt-Petersburg (2012): 19 p.

Manhart, L.E., Broad, J.M., Golden, M.R. “Mycoplasma genitalium: Should We Treat and How?” Clin Infect Dis 53.3 (2011): 129–42. DOI: 10.1093/cid/cir702

McGowin, C.L., Annan, R.S., Quayle, A.J., et al. “Persistent Mycoplasma genitalium Infection of Human Endocervical Epithelial Cells Elicits Chronic Inflammatory Cytokine Secretion.” Infect Immun 80.11 (2012): 3842–9. DOI: 10.1128/IAI.00819-12

Sobel, J.D., et al. “Mixed Vaginitis – More than coinfection and with therapeutic implications.” Curr Infect Dis Rep 15 (2013): 104–8.

Bebneva, T.N., Dobretsova, T.A. Mixed vaginal infections: a new ideology. Non-specific vaginal infections in the practice of obstetrician gynecologist. Newsletter. Ed. by V.E. Radzinsky, A.M. Savicheva. Moscow (2016).

Dubchak, A.E., Milevskyi, A.V., Dovgan, E.N. “Non-specific inflammatory diseases of the pelvic organs in women.” Women’s health 2.78 (2013): 51–5.

Gynecology: National guideline. Ed. by V.I. Kulakov, I.B. Manukhin, G.M. Savelieva. Moscow. GEOTAR-Media (2011): 1088 p.

Tatarchuk, T.F. “Evolution of treatment-diagnostic tactics in the syndrome of vaginal discharge.” Health of Ukraine, thematic issue “Gynecology” (2017).

Monsanto, S.P., Daher, S., Ono, E., et al. “Cervical cerclage placement decreases local levels of proinflammatory cytokines in patients with cervical insufficiency.” Am J Obstet Gynecol (2017).

Feghali, C.A, Wright, T.M. “Cytokines in acute and chronic inflammation.” Front Biosci 2 (1997): 12–26.

Practical guidance on infectious chemotherapy. Ed. by L.S. Strachunsky. NIIAH, SSMA (2007).

Reference book “COMPENDIUM 2016 – medicinal drugs”. Ed. by V.N. Kovalenko.

Instruction for medical use of drug Macmiror pills. РС № UA/5045/01/01, order of the MOH of Ukraine № 07, 05.01.2017.

De Filippo, V. “Effects of the Nifuratel-Nystatin combination in local therapy of cervico-vaginal inflammatory diseases.” Minerva Ginecol 32.1–2 (1980): 123–8.

Balmer, J. “Combination of nifuratel and nystatin (Macmiror complex) in the treatment of vulvovaginitis caused by a mixed fungal, bacterial and trichomonas infection. Multicenter European research.” Medical and social problems of the family 3–4 Vol. 17 (2012).

Grishchenko, O.V., Storchak, A.V. “Clinico-microbiological substantiation of the complex approach to the treatment of bacterial vaginosis.” Women’s health 7 (2014).

Chueshov, V.I. Industrial technology of medicines. MTK-Book; Publisher NFAU (2002).

Instruction for medical use of drug Macmiror complex vaginal cream. РС № UA/3934/01/01, order of the MOH of Ukraine № 695, 26.10.2015.

“Papillomavirus infection – a modern view of the problem.” Medical aspects of women’s health 4.109 (2017).

Sironi, M., Massimiliano, P., Transidico, M., et al. “Differential effect of benzydamine on pro-versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist.” Vecchi International Journal of Clinical and Laboratory Research 1 (2000): 17–19.

Czajka, R., et al. “Investigation of the effectiveness of benzidamine (Tantum Rose) in the form of vaginal lavage in the treatment of pain and discomfort in the perineal area in the early postpartum period.” Medical and social problems of the family 1 (2013).

A method of treating inflammatory diseases of the uterus. Information letter of the MOH of Ukraine № 35, 2014.

Instruction for medical use of drug Tantum Rosa vaginal solution. № UA/4012/02/01, order of the MOH of Ukraine № 1267, 22.11.2016.

Oboskalova, Т.А. “Features of the current course of infectious processes of the genital tract in women and the ways of their correction.” Effective pharmacotherapy. Obstetrics and gynecology 5 (2012).


GOST Style Citations


1. Сухих, Т.Г. Репродуктивное здоровье семьи // Материалы второго Международного конгресса по репродуктивной медицине «Репродуктивное здоровье семьи». – М., 2008. – С. 5–10.

2. Овсянникова, Т.В. Заболевания шейки матки. Клиника, диагностика, лечение: учебное пособие для врачей. – М.: МЕДпресс- информ, 2013. – 64 с.

3. Панченко, В.В. Клинико-морфологическая характеристика, оптимизация диагностики и лечения осложненной эктопии цилиндрического эпителия шейки матки: автореф. дисс. ... канд. мед. наук: спец. 14.01.01, 14.03.02. – Челябинск, 2014. – 16 с.

4. Бебнева, Т.Н. Роль инфекционных факторов в развитии доброкачественных и предраковых заболеваний шейки матки. – АНО «Открытые Медицинские Коммуникации», 2017–2018.

5. Гренкова, Ю.М. Воспалительные заболевания шейки матки у женщин репродуктивного и постменопаузального возраста: особенности клиники, диагностики и лечения: автореф. дис. ... канд. мед. наук: спец. 14.01.01. – Санкт-Петербург, 2012. – 19 с.

6. Manhart, L.E., Broad, J.M., Golden, M.R. “Mycoplasma genitalium: Should We Treat and How?” Clin Infect Dis 53.3 (2011): 129–42. DOI: 10.1093/cid/cir702

7. McGowin, C.L., Annan, R.S., Quayle, A.J., et al. “Persistent Mycoplasma genitalium Infection of Human Endocervical Epithelial Cells Elicits Chronic Inflammatory Cytokine Secretion.” Infect Immun 80.11 (2012): 3842–9. DOI: 10.1128/IAI.00819-12

8. Sobel, J.D., et al. “Mixed Vaginitis – More than coinfection and with therapeutic implications.” Curr Infect Dis Rep 15 (2013): 104–8.

9. Бебнева, Т.Н., Добрецова, Т.А. Смешанные вагинальные инфекции: новая идеология. Неспецифические вагинальные инфекции в практике акушера-гинеколога / Информационный бюллетень. Под ред. В.Е. Радзинского, А.М. Савичевой. – М., 2016.

10. Дубчак, А.Е. Неспецифические воспалительные заболевания органов малого таза у женщин / А.Е. Дубчак, А.В. Милевский, Е.Н. Довгань // Здоровье женщины. –2013. – №2 (78). – С. 51–55.

11. Гинекология: Национальное руководство / Под ред. В.И. Кулакова, И.Б.Манухина, Г.М.Савельевой. – М.: ГЭОТАР-Медиа, 2011. – 1088 с.

12. Татарчук, Т.Ф. Эволюция лечебно-диагностической тактики при синдроме вагинальных выделений / Т.Ф. Татарчук // Здоровье Украины, тематический номер «Гинекология». – 2017.

13. Monsanto, S.P., Daher, S., Ono, E., et al. “Cervical cerclage placement decreases local levels of proinflammatory cytokines in patients with cervical insufficiency.” Am J Obstet Gynecol (2017).

14. Feghali, C.A, Wright, T.M. “Cytokines in acute and chronic inflammation.” Front Biosci 2 (1997): 12–26.

15. Практическое руководство по инфекционной химиотерапии. Под ред. Л.С. Страчунского. – НИИАХ, СГМА, 2007.

16. Справочник «КОМПЕНДИУМ 2016 – лекарственные препараты». Под редакцией В.Н. Коваленко.

17. Інструкція до медичного застосування препарату Макмірор таблетки. РС № UA/5045/01/01, наказ МОЗ України № 07 від 05.01.2017.

18. De Filippo, V. “Effects of the Nifuratel-Nystatin combination in local therapy of cervico-vaginal inflammatory diseases.” Minerva Ginecol 32.1–2 (1980): 123–8.

19. Бальмер, Дж. Комбинация нифурателя и нистатина (Макмирор комплекс) в лечении вульвовагинитов, вызванных смешанной грибковой, бактериальной и трихомонадной инфекцией. Мультицентровое европейское исследование. – Медико- социальные проблемы семьи. – 2012. – №3–4 (Том 17).

20. Грищенко, О.В. Клинико-микробиологическое обоснование комплексного подхода к лечению бактериального вагиноза / О.В. Грищенко, А.В. Сторчак // Здоровье женщины. –2014. – №7.

21. Чуешов, В.И. Промышленная технология лекарств. – МТК-Книга; Издательство НФАУ, 2002.

22. Інструкція до медичного застосування препарату Макмірор комплекс вагінальний крем. РС № UA/3934/01/01, наказ МОЗ України № 695 від 26.10.2015.

23. Папилломавирусная инфекция – современный взгляд на проблему. Медичні аспекти здоров’я жінки. – 2017. –№4 (109).

24. Sironi, M., Massimiliano, P., Transidico, M., et al. “Differential effect of benzydamine on pro-versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist.” Vecchi International Journal of Clinical and Laboratory Research 1 (2000): 17–19.

25. Чайка, Р., и др. Исследование эффективности бензидамина (Тантум Роза) в форме вагинального лаважа при лечении болей и дискомфорта в перинеальной области в раннем послеродовом периоде / Р. Чайка и др. // Медико- социальные проблемы семьи». –2013. – №1.

26. Спосіб лікування запальних захворювань шійки матки. Інформаційний лист МОЗ України № 35, 2014.

27. Інструкція для медичного застосування лікарського засобу Тантум Роза розчин вагінальний. № UA/4012/02/01, наказ МОЗ України № 1267 від 22.11.2016.

28. Обоскалова, Т.А. Особенности современного течения инфекционных процессов половых путей у женщин и пути их коррекций / Т.А. Обоскалова // Эффективная фармакотерапия. Акушерство и гинекология. – 2012. –№5.





DOI: https://doi.org/10.18370/2309-4117.2018.39.16-20

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)